"AI is enabling us to not only increase the success and speed of our biologics discovery process, but also enhance the diversity of the biologics we discover," said AstraZeneca Senior Vice President Puja Sapra.
"We're proud to work closely with AstraZeneca to leverage our AI to bring novel treatments to oncology patients," said Absci CEO Sean McClain.
[
add
]
[
|
|
...
]